Announce Date | 05/01/2025 |
EPS Normalized Actual | $0.46 (Beat by $0.16) |
EPS GAAP Actual | $0.46 (Beat by $0.16) |
Revenue Actual | $1.718B |
Revenue Surprise | Beat by $1718M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.2699 |
EPS GAAP Estimate | $1.2699 |
Revenue Estimate | $1.84785324B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 11.15 | 13.23 | 10.29624 | 11.81171 | 1 |
Dec 2028 | 12.46 | 11.84 | 11.95211 | 12.96209 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.2 | -0.74835 | 1.718B | -1.16% | -106.86M |
FQ4 2024 (Dec 2024) | -0.58 | -0.58 | 1.602B | -5.43% | 1602M |
FQ3 2024 (Sep 2024) | 4.75 | 4.75 | 1.629B | 0.43% | 1629M |
FQ2 2024 (Jun 2024) | 3.55 | 3.55 | 1.703B | -0.12% | 1703M |
FQ1 2024 (Mar 2024) | 5.08 | 5.08 | 1.738B | 3.34% | 1738M |
FQ4 2023 (Dec 2023) | 0.25 | 0.25 | 1.689B | 5.98% | 1689M |
FQ3 2023 (Sep 2023) | 0 | 0 | 1.622B | 4.99% | 1622M |
FQ2 2023 (Jun 2023) | 0 | 0 | 1.705B | 13.02% | 1705M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.2699
Consensus Revenue Estimates
1.84785324B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.58227 | -- | 1.44527 | 1.65828 | 3 |
FQ2 2027 (Jun 2027) | 1.58135 | -- | 1.44443 | 1.65731 | 5 |
FQ1 2027 (Mar 2027) | 1.12533 | -- | 1.0279 | 1.17939 | 3 |
FQ4 2026 (Oct 2026) | 0 | -- | 0 | 0 | 7 |
FQ3 2026 (Jul 2026) | 0 | -- | 0 | 0 | 4 |
FQ2 2026 (Jun 2026) | 0 | -- | 0 | 0 | 3 |
FQ1 2026 (Mar 2026) | 0 | -INF | 0 | 0 | 6 |
FQ4 2025 (Oct 2025) | 1.19301 | 148.62 | 1.09366 | 1.25737 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 2B | -- | 1.87B | 2.07B | 3 |
FQ2 2027 (Jun 2027) | 1.98B | -- | 1.85B | 2.05B | 3 |
FQ1 2027 (Mar 2027) | 1.92B | -- | 1.79B | 1.99B | 3 |
FQ4 2026 (Oct 2026) | 1.73B | -- | 1.62B | 1.8B | 4 |
FQ3 2026 (Jul 2026) | 1.86B | -- | 1.74B | 1.94B | 6 |
FQ2 2026 (Jun 2026) | 1.86B | -- | 1.79B | 1.94B | 5 |
FQ1 2026 (Mar 2026) | 1.87B | 8.11 | 1.8B | 1.95B | 6 |
FQ4 2025 (Oct 2025) | 1.76B | 9.19 | 1.65B | 1.84B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
2
EPS # of in-lines
2
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.94835 | 0.2 | -0.74835 | -374.18% |
FQ4 2024 (Dec 2024) | -0.58 | -0.58 | 100% | |
FQ3 2024 (Sep 2024) | 4.75 | 4.75 | 100% | |
FQ2 2024 (Jun 2024) | 3.55 | 3.55 | 100% | |
FQ1 2024 (Mar 2024) | 5.08 | 5.08 | 100% | |
FQ4 2023 (Dec 2023) | 0.25 | 0.25 | 100% | |
FQ3 2023 (Sep 2023) | 0 | 0 | NAN% | |
FQ2 2023 (Jun 2023) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $1.82B | $1.72B | $-106.86M | -6.22% |
FQ4 2024 (Dec 2024) | $0B | $1.6B | $1602M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.63B | $1629M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.7B | $1703M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.74B | $1738M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.69B | $1689M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.62B | $1622M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.71B | $1705M | 100% |